Clinical stage biopharma company Proteostasis Therapeutics (PTI) announced positive preliminary results from a Phase 1 study for the treatment of cystic fibrosis
Categories
Other Industries
Marijuana is the new Tesla. Here is why
The last time marijuana and Tesla (TSLA) made an appearance in the same sentence, the automaker’s stock plunged 9%. That was when
Phillip Morris Q3 results beat estimates; maintains outlook
Phillip Morris International (PM) reported better-than-expected results for the third quarter sending the stock up 5% at 10:35 AM ET trading above
Danaher Q3 profit rises 15%, beats estimates
Danaher Corp. (DHR) reported a 16% increase in earnings for the third quarter driven by core revenue growth, solid operating margin expansion,
Nucor drops despite Q3 revenue and earnings beat
Nucor Corporation (NUE) beat market estimates on revenue and earnings for the third quarter of 2018, but the stock was down 2%
Novartis stock rises on upbeat Q3 results
Novartis AG (NVS) reported a 22% dip in earnings for the third quarter due to charges from the voluntary withdrawal of CyPass,
Snap-On delivers 25% jump in Q3 net income
Tools and equipment manufacturer Snap-On (SNA) on Thursday reported 25% increase in third-quarter net income to $2.85 per share, despite net sales
Kinder Morgan meets expectations on Q3 earnings but misses on revenues
Kinder Morgan Inc. (KMI) posted third-quarter 2018 earnings that came in line with expectations but missed the mark on revenues. Total revenues
Earnings Preview: What to expect from Schlumberger’s Q3 results
Brent crude prices are hovering around $80 per barrel. In early October, it eclipsed $86 mark, recording a four-year high for the
Alcoa rises on upbeat Q3 results, tightens 2018 EBITDA outlook
Aluminum giant Alcoa Corp. (AA) surpassed analysts views for third quarter revenue and earnings figures, sending the stock in the upward direction
Marijuana stocks slip after legalization in Canada
After Uruguay signed a legislation to approve the sale of recreational cannabis in December 2013, Canada became the second country in the
Fresh hope for GE Power after Trump lobbies for major deal with Iraq
Despite the deteriorating financial health and operational challenges, General Electrical (GE) has remained buoyant about its turnaround strategy and issued a positive
Abbott posts strong Q3 results, narrows full year outlook
Pharmaceutical giant Abbott Laboratories (ABT) delivered a 12% increase in third-quarter revenue to $7.7 billion, helped by a 43% increase in diagnostics
CSX stock fluctuates despite doubling profit in Q3
CSX Corp. (CSX) reported better-than-expected earnings in the recently ended third quarter and the stock was fluctuating in the extended hours of
UnitedHealth Group boosted by solid Q3 results and updated outlook
UnitedHealth Group (UNH) reported better-than-expected results for the third quarter of 2018 and raised its earnings guidance for the full year. Shares
Pharmaceuticals unit lifts Johnson & Johnson results in Q3
Medical devices giant Johnson & Johnson (JNJ) reported higher revenue and income in Q3, driven by strong sales of pharmaceuticals products. The
Pharma, medical devices units to drive Abbott’s Q3 results
Healthcare giant Abbott Laboratories (ABT) is set to report third-quarter results on Wednesday at 7:45 am EDT. Analysts project earnings to increase
Earnings Preview: What to expect from UnitedHealth’s Q3 results?
UnitedHealth Group (UNH) is slated to reports its third-quarter results on October 16 before the bell. The largest health insurer in the US
Earnings Preview: Higher expenses to weigh on Honeywell’s Q3
Honeywell International Inc. (HON) is scheduled to report earnings results for the third quarter of 2018 on Friday, October 19. Analysts expect
Biosimilars might haunt Johnson & Johnson in Q3 as well
Healthcare giant Johnson & Johnson’s (JNJ) third-quarter earnings results are due on Tuesday before the bell. While the constant threat from biosimilars
Earnings Preview: Higher rental rates to give United Rentals a lift in Q3
United Rentals Inc. (URI) is scheduled to report third quarter 2018 earnings results on Wednesday, October 17. Analysts expect the company to